Sunday, September 20, 2026

JP Morgan Chase Stock Bullish Momentum With A 4% Rise As Session Comes To An End On Monday

ViaNews Editorial Team

December 21, 2020

JP Morgan Chase Stock Bullish Momentum With A 4% Rise As Session Comes To An End On Monday

Shares of JP Morgan Chase rose 4.07% to $123.93 at 15:52 EST on Monday, after two successive sessions in a row of losses. The New York Stock Exchange is sliding 0.5% to $14,395.60, following yesterday's downward trend, This seems, up to now, a somewhat rough trend trading session today.

JP Morgan Chase's last close was $119.08, 13.85% under its 52-week high of $141.10.

JP Morgan Chase's Sales

JP Morgan Chase's sales growth is a negative 4.9% for the present quarter and a decline by 1.7% for the next. The company's growth estimates for the ongoing quarter is a negative 7% and positive 198.7% for the next.

JP Morgan Chase's Revenue

Year-on-year quarterly revenue growth grew by 2.7%, now sitting on 98.03B for the twelve trailing months.

JP Morgan Chase's Stock Yearly Top and Bottom Value

JP Morgan Chase's stock is valued at $123.93 at 15:52 EST, way under its 52-week high of $141.10 and way higher than its 52-week low of $76.91.

JP Morgan Chase's Moving Average

JP Morgan Chase's value is above its 50-day moving average of $116.36 and way above its 200-day moving average of $103.25.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com